POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 23 | / | 2017 | ||||||||
Date of issue: | 2017-06-16 | ||||||||||
Short name of the issuer | |||||||||||
KRKA | |||||||||||
Subject | |||||||||||
Acquisition of treasury shares | |||||||||||
Official market - legal basis | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
With a reference to the public notice from 25 July 2014, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 12 June 2017 up to and including 15 June 2017. Krka acquired 3,770 treasury shares in the total value of EUR 203,113 on the Ljubljana Stock Exchange as follows: - on 12 June: 349 shares at an average weighted price of EUR 53.63, - on 13 June: 1,353 shares at an average weighted price of EUR 54.00, - on 14 June: 666 shares at an average weighted price of EUR 53.98 and - on 15 June: 1,402 shares at an average weighted price of EUR 53.77. SKB d.d. and NLB d.d. were brokers in these transactions. The total number of treasury shares prior to these transactions was 549,671 representing 1.676% of all shares issued. The total number of treasury shares after these transactions is 553,441 representing 1.688% of all shares issued. | |||||||||||
Annexes | |||||||||||
File | Description |
KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
(fullname of the issuer) | |||||||||||||
KRKA | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
8501 | Nove Mesto | ||||||||||||
(post code) | (city) | ||||||||||||
Smarjeska | 6 | ||||||||||||
(street) | (number) | ||||||||||||
+386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nie dotyczy | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2017-06-16 | Jože Colarič | President of the management board |